Tomoko Sugihara

Articles by Tomoko Sugihara

94 Treatment Persistence and Dose Modifications in US Patients With HR+/HER2−, Node-Positive, Early Breast Cancer Treated With Adjuvant Abemaciclib

ByHatem Soliman, MD,Susan Dent, MD,Astra M. Liepa,Victoria J. Stefaniak,Minxuan Huang,Tomoko Sugihara,Katheryn Moreira,Kathryn Hudson,Matthew P. Goetz, MD

May 24th 2026

Latest Updated Articles

Trending on CancerNetwork

Sequencing Bispecifics and CAR T-Cell Therapy in Myeloma and AL Amyloidosis

Larger Prostates Showed Post-Radiotherapy Urinary Symptom Normalization

Weighing the Promise and Trade-offs of CAR NK Cell Therapy for Cancer

Can an All-Oral HMA Regimen Change Frontline Care in Unfit AML?

FDA Approves Tucatinib Combo as Maintenance in HER2+ Breast Cancer